TLR9 and BAFF: Their expression in patients with IgA nephropathy

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1469-1474

  Li, WeiWei ^a,b   Peng, Xiaofei ^a   Liu, Yuyuan ^a   Liu, Hong ^a   Liu, Fuyou ^a   He, Liyu ^a   Liu, Yang ^a   Zhang, Fan ^a   Guo, Chunyan ^a   Chen, Guochun ^a   Zhang, Lei ^a   Dong, Zheng ^a   Peng, Youming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BINZHOU PEOPLE S HOSPITAL   (China)

Author keywords

BAFF; IgA nephropathy; IgA1; TLR9

Indexed keywords

B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN A1; MESSENGER RNA; TOLL LIKE RECEPTOR 9; IMMUNOGLOBULIN A; TLR9 PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MESANGIUM CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; B-CELL ACTIVATING FACTOR; CASE-CONTROL STUDIES; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84905440776     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2359     Document Type: Article

References (33)

1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727, 1987.
2. Appel GB and Waldman M: The IgA nephropathy treatment dilemma. Kidney Int 69: 1939-1944, 2006. (Pubitemid 43924256)
3. Barratt J and Feehally J: IgA nephropathy. J Am Soc Nephrol 16: 2088-2097, 2005. (Pubitemid 41716440)
4. Julian BA and Novak J: IgA nephropathy: an update. Curr Opin Nephrol Hypertens 13: 171-179, 2004. (Pubitemid 38373139)
5. Lai KN: Pathogenesis of IgA nephropathy. Nat Rev Nephrol 8: 275-283, 2012.
6. Suzuki H, Suzuki Y, Narita I, et al: Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19: 2384-2395, 2008.
7. Goto T, Bandoh N, Yoshizaki T, et al: Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol 126: 260-269, 2008.
8. Suzuki S, Fujieda H, Sunaga H, et al: Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy. Clin Exp Immunol 119: 328-332, 2000. (Pubitemid 30073038)
9. Fujieda S, Suzuki, H, Sunaga, et al: Induction of IgA against Haemophilus parainfluenzae antigens in tonsillar mononuclear cells from patients with IgA nephropathy. Clin Immunol 95: 235-243, 2000. (Pubitemid 30346684)
10. McCluskie MJ, Weeratna RD and Davis HL: Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol Med 6: 867-877, 2000.
11. Kajiyama T, Suzuki Y, Kihara M, et al: Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy. Clin Dev Immunol 2011: 819646, 2011.
12. Liu H, Peng Y, Liu F, Xiao W, Zhang Y and Li W: Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy. Inflamm Res 60: 869-878, 2011.
13. Krieg AM and Vollmer J: Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 220: 251-269, 2007. (Pubitemid 350045572)
14. Krieg AM, Yi AK, Matson S, et al: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549, 1995.
15. Kaisho T and Akira S: Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol 22: 78-83, 2001. (Pubitemid 32667525)
16. Ashkar AA and Rosenthal KL: Toll-like receptor 9, CpG DNA and innate immunity. Curr Mol Med 2: 545-556, 2002. (Pubitemid 34982187)
17. Leadbetter EA, Rifkin IR and Marshak-Rothstein A: Toll-like receptors and activation of autoreactive B cells. Curr Dir Autoimmun 6: 105-122, 2003.
18. Schneider P, MacKay F, Steiner V, et al: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189: 1747-1756, 1999. (Pubitemid 29272691)
19. Moore PA, Belvedere O, Orr A, et al: BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263, 1999. (Pubitemid 29330000)
20. Craxton A, Magaletti D, Ryan EJ and Clark EA: Macrophage- and dendritic cell - dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471, 2003. (Pubitemid 36857815)
21. Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C and Cassatella MA: A G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 197: 297-302, 2003. (Pubitemid 36184236)
22. Nardelli B, Belvedere O, Roschke V, et al: Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97: 198-204, 2001. (Pubitemid 32061261)
23. Bergamin F, Vincent IE, Summerfield A and McCullough KC: Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol 37: 3122-3130, 2007. (Pubitemid 350131291)
24. Jego G, Pascual V, Palucka AK and Banchereau J: Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun 8: 124-139, 2005.
25. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P and Cerutti A: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3: 822-829, 2002.
26. McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE and Gommerman JL: BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol 241: 85-94, 2006. (Pubitemid 44649295)
27. Xin G, Shi W, Xu LX, Su Y, Yan LJ and Li KS: Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J Nephrol 26: 683-690, 2012.
28. Huang H, Peng Y, Liu H, Yang X and Liu F: Decreased CD4 +CD25+ cells and increased dimeric IgA-producing cells in tonsils in IgA nephropathy. J Nephrol 23: 202-209, 2010.
29. Pontarollo RA, Rankin R, Babiuk LA, et al: Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet Immunol Immunopathol 84: 43-59, 2002. (Pubitemid 34083578)
30. Fujieda S, Suzuki S, Sunaga H, Yamamoto H, Seki M, Sugimoto H and Saito H: Production of interferon-gamma by tonsillar mononuclear cells in IgA nephropathy patients. Acta Otolaryngol 120: 649-654, 2000. (Pubitemid 32521218)
31. Buchanan RM, Popowych Y, Arsic N, et al: B-cell activating factor (BAFF) promotes CpG ODN-induced B cell activation and proliferation. Cell Immunol 271: 16-28, 2011.
32. Buchanan R, Popowych Y, Dagenais C, et al: Interferon-gamma and B-cell activating factor (BAFF) promote bovine B cell activation independent of TLR9 and T-cell signaling. Vet Immunol Immunopathol 145: 453-463, 2012.
33. Ng LG, Ng CH, Woehl B, et al: BAFF costimulation of Toll-like receptor-activated B-1 cells. Eur J Immunol 36: 1837-1846, 2006. (Pubitemid 44089050)